Impact of uterine contractility on quality of life of women undergoing uterine fibroid embolization.

Autor: Fornazari, Vinicius Adami Vayego, Salazar, Gloria Maria Martinez, Vayego, Stela Adami, Nunes, Thiago Franchi, Goncalves, Belarmino, Szejnfeld, Jacob, Bonduki, Claudio Emilio, Goldman, Suzan Menasce, Szejnfeld, Denis
Předmět:
Zdroj: CVIR Endovascular; 11/12/2019, Vol. 2 Issue 1, pN.PAG-N.PAG, 1p
Abstrakt: Background: Although changes in uterine contractility pattern after uterine fibroid embolization (UFE) has already been assessed by cine magnetic resonance imaging (MRI), their impact on quality of life outcomes has not been evaluated. The purpose of this study was to evaluate the impact of uterine contractility on the quality of life of women undergoing UFE measured by the Uterine Fibroid Symptom and Quality of Life questionnaire (UFS-QOL). Results: A total of 26 patients were included. MRI scans were acquired 30–7 days before and 6 months after UFE for all patients. The UFS-QOL was applied in person on first MRI exam day and 1 year after UFE and the outcomes were analyzed according to the groups of evolution pattern of uterine contractility: Group A: Unchanged Uterine Contractility Pattern, 38%; Group B: Favorable Modified Uterine Contractility Pattern, 50%; and Group C: Loss of Uterine Contractility, 11%. All UFE patients presented a reduction in the mean score for symptoms and increase in mean scores on quality of life. All patients in this cohort presented a reduction in mean symptom score and increase in the mean score of quality of life subscales. Group A had more relevant complaints regarding their sense of self-confidence; Group B presented worse sexual function scores before UFE, which improved after UFE compared to Group A. Conclusions: Significant improvement in symptoms, quality of life, and uterine contractility was observed after UFE in women of reproductive age with symptomatic fibroids. Functional uterine contractility seems to have a positive impact on quality of life and sexual function in this population. Level of evidence: Level 3, Non-randomized controlled cohort/follow-up study. [ABSTRACT FROM AUTHOR]
Databáze: Complementary Index
Externí odkaz: